MeiraGTx Holdings (MGTX) EBT (2017 - 2025)
MeiraGTx Holdings (MGTX) posted EBT of $15.9 million for Q4 2025, up 132.46% on a QoQ basis from -$49.0 million in Q3 2025, and up 149.36% year-over-year from $6.4 million in Q4 2024.
MeiraGTx Holdings (MGTX) EBT (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' EBT history runs 9 years deep, the most recent figure standing at $15.9 million for Q4 2025.
- Quarterly EBT rose 149.36% year-over-year to $15.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$122.1 million (up 29.69% YoY) and the FY2025 annual result came in at -$287.2 million, up 7.19% from the prior year.
- EBT was $15.9 million for Q4 2025 at MeiraGTx Holdings, up from -$49.0 million in the prior quarter.
- Across five years, EBT topped out at $15.9 million in Q4 2025 and bottomed at -$51.0 million in Q2 2024.
- A 5-year average of -$29.3 million and a median of -$31.8 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT plunged 927.97% — and 2025, when it soared 149.36%.
- MeiraGTx Holdings' EBT stood at -$4.3 million in 2021, then plunged by 927.97% to -$44.0 million in 2022, then soared by 114.9% to $6.5 million in 2023, then slumped by 591.63% to -$32.2 million in 2024, then surged by 149.36% to $15.9 million in 2025.
- Business Quant data shows MGTX's EBT at $15.9 million in Q4 2025, -$49.0 million in Q3 2025, and -$41.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 15.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.89 Mn |
| Sep 30, 2025 | -48.96 Mn |
| Jun 30, 2025 | -41.42 Mn |
| Mar 31, 2025 | -47.63 Mn |
| Dec 31, 2024 | -32.20 Mn |
| Sep 30, 2024 | -41.50 Mn |
| Jun 30, 2024 | -51.05 Mn |
| Mar 31, 2024 | -48.93 Mn |
| Dec 31, 2023 | 6.55 Mn |
| Sep 30, 2023 | -35.62 Mn |
| Jun 30, 2023 | -31.49 Mn |
| Mar 31, 2023 | -34.28 Mn |
| Dec 31, 2022 | -43.96 Mn |
| Sep 30, 2022 | -24.41 Mn |
| Jun 30, 2022 | -25.08 Mn |
| Mar 31, 2022 | -30.09 Mn |
| Dec 31, 2021 | -4.28 Mn |
| Sep 30, 2021 | -23.75 Mn |
| Jun 30, 2021 | -21.67 Mn |
| Mar 31, 2021 | -23.13 Mn |